Pulmonologiya : Impact Factor & More
eISSN: 2541-9617pISSN: 0869-0189
Share this on:
Key Metrics
CiteScore 
0.7
SNIP
0.36
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Pulmonologiya
Pulmonologiya Journal Specifications
Indexed in the following public directories
Scopus 
SJR
| Overview | |
| Publisher | Pulmonology LLC |
Planning to publish in Pulmonologiya ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Pulmonologiya
Clinical and demographic characteristics of patients with severe uncontrolled bronchial asthma in the Russian Federation: interim results of the CORSAR study
- 17 Apr 2026
- PULMONOLOGIYA
Efficiency of regular follow-up in patients with cystic fibrosis in the Moscow region
- 17 Apr 2026
- PULMONOLOGIYA
The experience of using triple targeted therapy (elexacaftor/ tezacaftor/ivacaftor) in a patient with cystic fibrosis complicated by cystic fibrosis-related diabetes
- 17 Apr 2026
- PULMONOLOGIYA
Clinical “masks” of congenital pathology of the bronchopulmonary system
- 17 Apr 2026
- PULMONOLOGIYA
Efficacy and safety of elexacaftor/tezacaftor/ivacaftor therapy in cystic fibrosis after 36 months of therapy
- 17 Apr 2026
- PULMONOLOGIYA
Chief Editor Alexander G. Chuchalin responds to readers’ letters
- 17 Apr 2026
- PULMONOLOGIYA
Clinical and demographic characteristics of patients with severe uncontrolled bronchial asthma in the Russian Federation: interim results of the CORSAR study
- 17 Apr 2026
- PULMONOLOGIYA
Efficiency of regular follow-up in patients with cystic fibrosis in the Moscow region
- 17 Apr 2026
- PULMONOLOGIYA
The experience of using triple targeted therapy (elexacaftor/ tezacaftor/ivacaftor) in a patient with cystic fibrosis complicated by cystic fibrosis-related diabetes
- 17 Apr 2026
- PULMONOLOGIYA
Clinical “masks” of congenital pathology of the bronchopulmonary system
- 17 Apr 2026
- PULMONOLOGIYA
Efficacy and safety of elexacaftor/tezacaftor/ivacaftor therapy in cystic fibrosis after 36 months of therapy
- 17 Apr 2026
- PULMONOLOGIYA
Chief Editor Alexander G. Chuchalin responds to readers’ letters
- 17 Apr 2026
- PULMONOLOGIYA
FAQs on Pulmonologiya
How many articles did Pulmonologiya publish last year? 
What is the eISSN & pISSN for Pulmonologiya?
What is Citescore for Pulmonologiya?
What is SNIP score for Pulmonologiya?
Who is the publisher of Pulmonologiya?
